NCT00154011View on ClinicalTrials.gov

Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone.

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

June 30, 2006

Conditions
Healthy Subjects
Interventions
DRUG

rosiglitazone (drug)

Trial Locations (1)

01307

Institute of Clinical Pharmacology, Dresden

All Listed Sponsors
lead

Technische Universität Dresden

OTHER

NCT00154011 - Investigation of Vascular Relaxing Effects of the Antidiabetic Rosiglitazone. | Biotech Hunter | Biotech Hunter